Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn։
”During my stay in Lisbon I had a privilege to give a lecture for Polish cardiologists about ‘Anticoagulation in specific situations’ during special pre-ACVC event.
Anticoagulation in real life causes lot of dilemmas, and we are increasingly forced to make individualized decisions and move towards patient-oriented precise medicine.
With Christophe Vandenbriele we wrote last year one of the Association for Acute Cardio Vascular Care – ACVC Clinical Decision Making Toolkit chapters: 10.2 Managing anticoagulation in critically ill in specific situations, which includes i.e. bleeding on OAC, anticagulation and hemolysis during MCS, heparin-induced thrombocytopenia, and MV thrombosis.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders